
First Trust NYSE Arca Biotechnology UCITS ETF
First Trust NYSE Arca Biotechnology UCITS ETF (DE:1FU6) Price & Chart
DE:1FU6 ETF Chart & Stats
- Day’s Range
- EUR 29.54 - EUR 29.54
- 52-Week Range
- EUR 19.93 - EUR 30.00
- Previous Close
- EUR 29.21
- Volume
- 0
- Average Volume (3M)
- 142
- AUM
- 18.25M
- NAV
- 33.22
- Expense Ratio
- 0.63%
- Holdings Count
- 31
- Beta
- 0.62
- Inception Date
- May 27, 2020
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 550,002
- Standard Deviation
- N/A
ETF Overview
First Trust NYSE Arca Biotechnology UCITS ETF
The First Trust NYSE Arca Biotechnology UCITS ETF, trading under the ticker DE:1FU6, is a specialized investment vehicle designed for those seeking targeted exposure within the dynamic health care sector. This ETF zeroes in on the biotechnology niche, a frontier of medical innovation where groundbreaking developments shape the future of health care. By investing in this fund, investors gain access to a curated portfolio of companies at the forefront of biotech advancements, ranging from genetic sequencing to cutting-edge pharmaceuticals and beyond. This ETF is not only a gateway to potential high-growth opportunities but also a means to align one's investment strategy with the rapidly evolving landscape of biotechnology. Suitable for investors with a keen interest in health care innovations, the First Trust NYSE Arca Biotechnology UCITS ETF offers a strategic approach to capturing the potential upside of the biotech revolution while navigating the complexities of this specialized market.
- Asset Class
- Equity
- Region
- North America
- Issuer
- First Trust
- Index Tracked
- NYSE Arca Biotechnology (TR)
- Ticker Symbol
- DE:1FU6
DE:1FU6 ETF News


Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Study Overview: Neurocrine Biosciences’ official Phase 2 study, “A Prospective, Long-Term, Interventional, Active Extension Study to Evaluate the Safety










